TY - JOUR
T1 - The digital transformation of hepatology
T2 - The patient is logged in
AU - Wu, Tiffany
AU - Simonetto, Douglas A.
AU - Halamka, John D.
AU - Shah, Vijay H.
N1 - Publisher Copyright:
© 2022 American Association for the Study of Liver Diseases.
PY - 2022/3
Y1 - 2022/3
N2 - The rise in innovative digital health technologies has led a paradigm shift in health care toward personalized, patient-centric medicine that is reaching beyond traditional brick-and-mortar facilities into patients’ homes and everyday lives. Digital solutions can monitor and detect early changes in physiological data, predict disease progression and health-related outcomes based on individual risk factors, and manage disease intervention with a range of accessible telemedicine and mobile health options. In this review, we discuss the unique transformation underway in the care of patients with liver disease, specifically examining the digital transformation of diagnostics, prediction and clinical decision-making, and management. Additionally, we discuss the general considerations needed to confirm validity and oversight of new technologies, usability and acceptability of digital solutions, and equity and inclusivity of vulnerable populations.
AB - The rise in innovative digital health technologies has led a paradigm shift in health care toward personalized, patient-centric medicine that is reaching beyond traditional brick-and-mortar facilities into patients’ homes and everyday lives. Digital solutions can monitor and detect early changes in physiological data, predict disease progression and health-related outcomes based on individual risk factors, and manage disease intervention with a range of accessible telemedicine and mobile health options. In this review, we discuss the unique transformation underway in the care of patients with liver disease, specifically examining the digital transformation of diagnostics, prediction and clinical decision-making, and management. Additionally, we discuss the general considerations needed to confirm validity and oversight of new technologies, usability and acceptability of digital solutions, and equity and inclusivity of vulnerable populations.
UR - http://www.scopus.com/inward/record.url?scp=85123948376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123948376&partnerID=8YFLogxK
U2 - 10.1002/hep.32329
DO - 10.1002/hep.32329
M3 - Review article
C2 - 35028960
AN - SCOPUS:85123948376
SN - 0270-9139
VL - 75
SP - 724
EP - 739
JO - Hepatology
JF - Hepatology
IS - 3
ER -